The Economic Times Healthcare and Biotech News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Contraceptive companies, CMSS spar over tenders
The All India Condom Manufacturer Association, which includes various companies that manufacture condom brand Nirodh, has written to the government highlighting haphazard handling of procurement by CMSS after it cancelled the condom tenders twice in the current year. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 6, 2023 Category: Pharmaceuticals Source Type: news

India to extend its global presence on pharmaceutical market with BRICS plus membership
The VIII International Conference on Antimonopoly Policy at Moscow's Skolkovo Innovation Center focused on enforcing competition laws in the pharmaceutical market. Representatives from Indian antitrust authorities expressed intent to support competition laws enforcement in information disclosure and patent regulation against global pharmaceutical monopolies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 6, 2023 Category: Pharmaceuticals Source Type: news

Venus Remedies gets marketing authorisation from Philippines, Saudi Arabia for three oncology drugs
Pharma major Venus Remedies on Wednesday said it has received marketing authorisation from Philippines and Saudi Arabia for three oncology drugs. In a statement, the Panchkula-based company said it has received regulatory approval from Philippines, the second largest market in the Association of Southeast Asian Nations (ASEAN) region, for chemotherapy drug paclitaxel and zoledronic acid. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 6, 2023 Category: Pharmaceuticals Source Type: news

Lupin gets USFDA nod for generic smoking cessation treatment tablets
Pharma major Lupin Ltd on Wednesday said it has received approval from the US health regulator to market its generic Varenicline tablets indicated for use as an aid to smoking cessation treatment. The approval by the US FDA is for the abbreviated new drug application for Varenicline tablets of strengths 0.5 mg and 1 mg, Lupin said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 6, 2023 Category: Pharmaceuticals Source Type: news

Sun Pharma subsidiary partners with Aclaris Therapeutics for licensing agreement
As per the pact, Aclaris grants Sun Pharma exclusive rights to specific patents for using deuruxolitinib, Sun Pharma's JAK inhibitor, or other isotopic forms of ruxolitinib, specifically for treating alopecia areata (AA) or androgenetic alopecia (AGA). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 6, 2023 Category: Pharmaceuticals Source Type: news

Emcure Pharma gets relief in $950-million lawsuit
The US district judge James Robart upheld the Indian drug maker's argument that the court lacked jurisdiction over the company and dismissed the case without prejudice, which means it can be refiled. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 5, 2023 Category: Pharmaceuticals Source Type: news

India among 8 nations seeking 5-year patent waiver for Covid diagnostics
In a submission to the World Trade Organization, they said that diagnostics and therapeutics are "essential tools for a comprehensive approach to fight the pandemic, that it is not over". (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 5, 2023 Category: Pharmaceuticals Source Type: news

Technology has important role to play in future of biotech: Biocon chief
Biocon executive chairperson Kiran Mazumdar-Shaw has emphasized the importance of technology in the future of biotechnology and product development. She believes that it would be great to see an idea go from laboratory to market in less than a year. Mazumdar-Shaw believes that technology can significantly accelerate the process of bringing new medications to market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 5, 2023 Category: Pharmaceuticals Source Type: news

It's still a man's world when it comes to healthcare leadership, salaries
Despite a significant presence of female workers in entry level roles, the report showed a significant under-representation of women in leadership roles, especially at the executive and board levels, across healthcare sub-sectors. Most women are focused on the frontline in low-paying jobs and women across the healthcare workforce, on average, earn 34% less than their male counterparts. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 4, 2023 Category: Pharmaceuticals Source Type: news

New India-UK research to trial easy-to-use test to cut antibiotic resistance
DOSA2, as the latest phase is known, is coordinated by the University of Edinburgh and includes partners at the University of the Arts London, Silchar Medical College, Assam University and the IIT Delhi. "Through our work, we hope to help slow the emergence of drug-resistant infections and improve the ability to diagnose and treat them," said Dr Mike Strange, Head of Global Health, LifeArc. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 4, 2023 Category: Pharmaceuticals Source Type: news

India finds quality issues with cough syrup linked to Cameroon deaths
Tests of a cough syrup linked to deaths in Cameroon have revealed quality issues in at least one of five samples taken by Indian authorities, according to unnamed sources. Naturcold syrup, manufactured by Riemann Labs, is one of three Indian-made cough syrups implicated in the deaths of at least 141 children in Cameroon, Gambia, and Uzbekistan. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 4, 2023 Category: Pharmaceuticals Source Type: news

Over 50 cough syrup makers fail quality tests
Likewise, Central Drugs Testing Laboratory (CDTL) Mumbai analysed 523 samples, out of which 18 samples from 10 firms failed quality tests. Regional Drugs Testing Laboratory (RDTL) Chandigarh released 284 test reports, and 23 samples from 10 firms were NSQ. Indian Pharmacopoeia Commission (IPC) Ghaziabad released 502 reports, out of which 29 from nine firms failed the quality test. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 3, 2023 Category: Pharmaceuticals Source Type: news

Atria convergence posts Rs 2,273-cr top line in FY23
The company's net profit increased 3.5% to '353 crore amid a 6% jump in expenses to '1,826 crore. Employee benefit expenses rose 15% to '556 crore. ACT provides broadband and cable TV services in cities and towns in Karnataka, Andhra Pradesh, Telangana, Tamil Nadu and Delhi-NCR. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 3, 2023 Category: Pharmaceuticals Source Type: news

Atria convergence posts '2,273-cr top line in FY23
The company's net profit increased 3.5% to '353 crore amid a 6% jump in expenses to '1,826 crore. Employee benefit expenses rose 15% to '556 crore. ACT provides broadband and cable TV services in cities and towns in Karnataka, Andhra Pradesh, Telangana, Tamil Nadu and Delhi-NCR. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 3, 2023 Category: Pharmaceuticals Source Type: news

Maker of Wegovy, Ozempic showers money on US obesity doctors
Novo Nordisk, a Danish pharmaceutical company renowned for its diabetes medicines, is now positioning itself as the world's leading weight-loss company. The company aims to target the global population of 764 million people with obesity, with the United States being its most lucrative market. In the U.S., where over two-thirds of adults are either overweight or obese, Novo charges customers $1,300 per month for the weekly injection of Wegovy. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 2, 2023 Category: Pharmaceuticals Source Type: news